Hemoptysis is a common respiratory symptom. One of the most common cause for hemoptysis in India is pulmonary tuberculosis. Pulmonary tuberculosis is more common in young and usually present with fever, cough and hemoptysis. Chest x ray usually shows upper lobe lesions. When sputum examination for AFB smear is negative and chest radiology is not typical of tuberculosis further investigations are indicated for definitive diagnosis. We report a rare case of pleomorphic carcinoma of lung in a young female mimicking pulmonary tuberculosis. Definitive diagnosis was established by biopsy from the lung lesion.
In India, the most common cause for chronic cough with fever, hemoptysis, and weight loss in a young person with no risk factors for malignancy is pulmonary tuberculosis. Bronchogenic carcinoma is unusual in this age group with no risk factors for the same. She had no purulent or copious sputum and no postural variation of respiratory symptoms to suspect bronchiectasis or lung abscess. 
Introduction
H emoptysis is a common symptom in patients with lung disease. Proper history, physical examination and appropriate investigations are essential to establish a proper diagnosis in patients with hemoptysis.
Case Report
A 38-year-old female, homemaker, presented with complaints of cough associated with scanty mucoid expectoration, weight loss, and fever on and off for the past 2 months. She had three episodes of scanty hemoptysis for the past 1 month. She had no postural variation in cough or expectoration. She had no chest pain, change in voice, breathlessness, or other systemic symptoms. She had no history of any respiratory illness. There was no other significant illness in the past. She was a nonsmoker. She had no history of exposure to passive smoking. She did not have any other addictions or substance abuse. In a suspected case of pulmonary tuberculosis, diagnostic investigation is sputum for AFB smear. Chest X-ray may show the lung parenchymal lesions which may be suggestive of tuberculosis, but it is not a diagnostic investigation.
Sputum AFB smear done twice by RNTCP microscopy center was negative.
Question 4: What is the next investigation in this patient? 1. Computed tomography (CT) scan of the thorax 2. Thoracic ultrasound 3. Chest X-ray PA view 4. Sputum culture sensitivity 5. Sputum cytology for malignant cells.
Answer: 3: Chest X-ray PA view
Investigations are to be done in sequential order with simple, basic, and most informative investigation first. In a suspected case of pulmonary tuberculosis where sputum AFB smear is negative, the next investigation is chest X-ray PA view. Her erythrocyte sedimentation rate was 36 mm. Fasting blood sugar was normal. HIV serology was nonreactive. Sputum culture did not grow any organism. Sputum cytology for malignant cells was negative.
Question 5: What is the next investigation in this patient? 1. Magnetic resonance imaging (MRI) of the thorax 2. CT scan of the thorax 3. Thoracic ultrasound 4. Bronchoscopy 5. Spirometry. Answer: 2: Before bronchoscopy, it is ideal to get further information regarding the lung lesion. CT scan of the thorax is preferred over MRI of the thorax in the evaluation of parenchymal lung diseases. Thoracic ultrasound may not be helpful as the chest X-ray showed parenchymal lung lesion. Spirometry is not indicated in this patient as there is no history of breathlessness and airway disease is not suspected. Moreover, history of hemoptysis without a definitive diagnosis at this stage is a relative contraindication for spirometry.
Contrast-enhanced CT scan of the chest Figures 2 and 3 was done which showed heterogeneously enhancing ill-defined soft-tissue density mass lesion in the right upper lobe extending to the right pulmonary artery and mediastinum, suggestive of bronchogenic carcinoma. Bronchoscopy was done which showed a fleshy growth occluding the right upper lobe bronchus covered by a blood clot. Bronchoscopic biopsy was done which was noninformative. Hence, percutaneous CT-guided biopsy was done which showed nonsmall cell cancer 
Discussion
Pulmonary pleomorphic carcinoma (PC) is a rare malignant tumor of the lung and its incidence has been reported to range from 0.1% to 0.4% of all lung cancers.
Pleomorphic carcinoma is one of the five subtypes of sarcomatoid carcinoma. [1] Pleomorphic lung carcinoma is either poorly differentiated adenocarcinoma or squamous cell carcinoma or large-cell carcinoma containing sarcomatoid components of the spindle or giant cells in at least 10% of the cells, or a carcinoma comprised entirely of giant cells and spindle cells. Common symptoms in these patients are chronic cough, hemoptysis, chest pain, and fever. [2] The mean age at diagnosis is 60-65 years. Male-to-female ratio is 2.1:1 with strong correlation with smoking. [2] Diagnosis is by pathological examination. Pleomorphic carcinoma usually has an aggressive clinical course and a worse outcome than other nonsmall cell lung cancer. [2] In all operable cases, surgery is the first choice. [3] Palliative chemotherapy is used in inoperable cases. [4] Targeted therapy may be administered for epidermal growth factor receptor mutation patients. More aggressive management strategy may be needed due to its tendency for early metastasis and high relapse rate. Overall prognosis is poor. According to Fishback et al. and Rossi et al., median survival rate is 8-19 months. [5] Pleomorphic carcinoma has a tendency to grow rapidly and to invade adjacent structures early. [6] Several favorable prognostic factors have been reported, including complete surgical resection, no lymph node metastasis, lower pathologic stages, and tumor necrosis. [6] Pleural involvement is a bad prognostic factor. Chang et al. reported that seven patients who received surgical resections were found distal metastases within a few months. [2] Metastases occurred in the bone and organs, including the brain, adrenal gland, esophagus, jejunum, rectum, and kidney. Advanced pulmonary PC was found to respond poorly to the platinum-and nonplatinum-based chemotherapy regimens. Conventional radiation therapy has had little effect on pleomorphic lung cancer. Chang et al. also reported that the median survival time was only 3 months for nine inoperable cases that were treated by chemoradiotherapy.
Bronchogenic carcinoma is rare in a young female without any risk factors. History, clinical examination, and radiological findings may give a clue regarding whether a lesion is benign or malignant. Final confirmation is by histopathology. Bronchogenic carcinoma in younger patients is usually very aggressive. Early diagnosis and treatment may improve the survival rate. Smoking is the main risk factor. Adenocarcinoma is the most common cell type. [7] Squamous cell and small cell are rare. Distant metastasis is more common at the time of diagnosis. Overall survival may be better compared to that in patients who were treated aggressively. [7] This patient was inoperable as the tumor was involving the right pulmonary artery and mediastinum. She was referred to the oncology department for palliative chemotherapy.
Conclusion
When symptoms and chest X-ray are not typical of tuberculosis in a patient where sputum AFB smear is negative, further evaluation should be done to find a definitive diagnosis.
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